Quarterly report pursuant to Section 13 or 15(d)

Contingencies - Narrative (Details)

v3.24.2.u1
Contingencies - Narrative (Details) - USD ($)
 3 Months Ended 6 Months Ended
Aug. 02, 2023
Feb. 13, 2023
Jan. 18, 2023
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Aug. 17, 2023
Loss Contingencies [Line Items]                
Other interest expense       $ 0 $ 4,258 $ 0 $ 6,705  
Legal judgment interest expense       75,189 $ 182,171 150,146 $ 182,171  
Coverage received to cover legal expenses       $ 5,000,000   5,000,000    
Wendy Cunning Vs Skye Bioscience, Inc                
Loss Contingencies [Line Items]                
Total compensatory damages $ 1,200,008              
Loss contingency, appeal bond               $ 9,080,202
Potential outcome     $ 6,053,468          
Other interest expense           $ 384,896    
Loss contingency, interest rate on damages   4.90%            
Loss contingency, interest rate on legal fees   5.38%            
Wendy Cunning Vs Skye Bioscience, Inc | Economic Damages                
Loss Contingencies [Line Items]                
Total compensatory damages     512,500          
Wendy Cunning Vs Skye Bioscience, Inc | Non-Economic Damages                
Loss Contingencies [Line Items]                
Total compensatory damages     840,960          
Wendy Cunning Vs Skye Bioscience, Inc | Punitive Damages                
Loss Contingencies [Line Items]                
Total compensatory damages     $ 3,500,000          
Loss contingency accrual, period increase (decrease) $ 151,842